Organized by the American Society of Gene & Cell Therapy (ASGCT), this annual meeting is widely recognized as the largest and most comprehensive event in the gene and cell therapy field, attracting professionals from academia, biotechnology companies, pharmaceutical firms, and regulatory organizations.

The conference features cutting-edge scientific presentations, clinical research updates, and discussions on the latest technological advances in areas such as gene editing, viral vector development, cell engineering, and translational medicine.

Attendees can participate in scientific symposia, abstract presentations, workshops, and poster sessions, while the exhibition area showcases new laboratory technologies, biotech tools, and therapeutic platforms driving innovation in genetic medicine.

The meeting also fosters collaboration between academic researchers, clinicians, patient advocacy groups, regulatory agencies, and biotechnology investors working together to accelerate the development of life-changing therapies.